Open Access Pre-publication history

Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

Lambros Vamvakas, Alexios Matikas, Athanasios Karampeazis, Dora Hatzidaki, Stelios Kakolyris, Charalampos Christophylakis, Ioannis Boukovinas, Aris Polyzos, Vassilis Georgoulias and John Souglakos*

BMC Cancer 2014, 14:277  doi:10.1186/1471-2407-14-277

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 24 Dec 2013
Reviewer's Report Wataru Ichikawa 04 Feb 2014
Reviewer's Report Sook-Ryun Park 17 Feb 2014
Resubmission - Version 2 Manuscript Author's comment 24 Feb 2014
Resubmission - Version 3 Manuscript 05 Mar 2014
Reviewer's Report Wataru Ichikawa 06 Mar 2014
Reviewer's Report Sook-Ryun Park 19 Mar 2014
Resubmission - Version 4 Manuscript Author's comment 01 Apr 2014
Resubmission - Version 5 Manuscript Author's comment 09 Apr 2014
Editorial acceptance 16 Apr 2014
Published 22 Apr 2014